Menest

Low Testosterone, moderate Vulvovaginal atrophy, Hot flashes + 6 more

Treatment

12 FDA approvals

20 Active Studies for Menest

What is Menest

Esterified estrogens

The Generic name of this drug

Treatment Summary

Esterified estrogens are a combination of man-made estrogens used to treat symptoms of menopause like hot flashes, vaginal dryness, and irritation. It can also help prevent and treat osteoporosis. The main component of this medication is estrone and it contains 75-85% sodium estrone sulfate and 6-15% sodium equilin sulfate.

Menest

is the brand name

image of different drug pills on a surface

Menest Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Menest

Esterified estrogens

1977

8

Approved as Treatment by the FDA

Esterified estrogens, also known as Menest, is approved by the FDA for 12 uses including severe menopausal vulvovaginal atrophy and Hypogonadism .

severe menopausal vulvovaginal atrophy

Helps manage severe menopausal vulvovaginal atrophy

Hypogonadism

Helps manage Hypogonadism

Metastatic Breast Cancer

Advance Directives

Hot flashes

Helps manage Menopause

moderate Menopausal Vasomotor Symptoms

Helps manage moderate Menopausal Vasomotor Symptoms

Premature Ovarian Failure (POF)

Helps manage Premature Ovarian Failure (POF)

Low Testosterone

Helps manage Hypogonadism

Premature Menopause

Helps manage Premature Ovarian Failure (POF)

Menopause

Helps manage severe Vasomotor Symptoms Associated With Menopause

moderate Vulvovaginal atrophy

Helps manage moderate Vulvovaginal atrophy

Metastatic Breast Cancer

Effectiveness

How Menest Affects Patients

Estrogens are hormones that help with the growth and maintenance of female reproductive organs and features. Estradiol is a major type of estrogen found in humans, and is more powerful than other types. It is the main estrogen released before menopause.

How Menest works in the body

Estrogens help to balance the levels of hormones that stimulate the ovaries. Estrogen replacement lowers the amount of these hormones in the body, helping to keep them in the correct range.

When to interrupt dosage

The suggested amount of Menest is contingent upon the diagnosed disorder, like moderate Menopausal Vasomotor Symptoms, moderate Vulvovaginal atrophy and Menopause. The quantity of dosage is dependent upon the technique of administration, as stated in the table beneath.

Condition

Dosage

Administration

Metastatic Breast Cancer

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

Hot flashes

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

Low Testosterone

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

moderate Vulvovaginal atrophy

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

Premature Menopause

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

Advance Directives

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

severe menopausal vulvovaginal atrophy

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

moderate Menopausal Vasomotor Symptoms

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

Menopause

, 1.25 mg, 0.625 mg, 0.3 mg, 2.5 mg

Oral, Tablet, coated - Oral, , Tablet, coated, Tablet, Tablet - Oral, Tablet, film coated - Oral, Tablet, film coated

Warnings

Menest Contraindications

Condition

Risk Level

Notes

Neoplasms, Hormone-Dependent

Do Not Combine

suspected pregnancy

Do Not Combine

Thromboembolism

Do Not Combine

Breast

Do Not Combine

Thrombophlebitis

Do Not Combine

abnormal genital bleeding

Do Not Combine

estrogen-dependent neoplasia

Do Not Combine

Breast Cancer

Do Not Combine

There are 20 known major drug interactions with Menest.

Common Menest Drug Interactions

Drug Name

Risk Level

Description

Anastrozole

Major

The therapeutic efficacy of Anastrozole can be decreased when used in combination with Esterified estrogens.

Dasabuvir

Major

The risk or severity of liver enzyme elevations can be increased when Esterified estrogens is combined with Dasabuvir.

Exemestane

Major

The therapeutic efficacy of Exemestane can be decreased when used in combination with Esterified estrogens.

Ombitasvir

Major

The risk or severity of liver enzyme elevations can be increased when Esterified estrogens is combined with Ombitasvir.

Ospemifene

Major

The risk or severity of adverse effects can be increased when Esterified estrogens is combined with Ospemifene.

Menest Toxicity & Overdose Risk

The toxic dose of the drug when given by injection to rats is 325mg/kg, while the toxic dose in mice given the drug intravenously is 1740mg/kg. The toxic dose of the drug when given orally to rats is greater than 5000mg/kg.

Menest Novel Uses: Which Conditions Have a Clinical Trial Featuring Menest?

111 active clinical trials are assessing the potential of Menest to mitigate severe menopausal vulvovaginal atrophy, Metastatic Breast Cancer and Advance Directives.

Condition

Clinical Trials

Trial Phases

Premature Menopause

0 Actively Recruiting

Advance Directives

6 Actively Recruiting

Phase 1, Phase 2, Not Applicable

moderate Menopausal Vasomotor Symptoms

0 Actively Recruiting

Menopause

0 Actively Recruiting

severe menopausal vulvovaginal atrophy

0 Actively Recruiting

Low Testosterone

6 Actively Recruiting

Phase 4, Phase 2, Phase 1

Hot flashes

19 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Early Phase 1, Phase 3

Metastatic Breast Cancer

1 Actively Recruiting

Phase 1, Phase 2

moderate Vulvovaginal atrophy

0 Actively Recruiting

Menest Reviews: What are patients saying about Menest?

5

Patient Review

8/13/2009

Menest for "Change of Life" Signs

I've liked taking this drug, but I think I need a stronger mg.

5

Patient Review

2/28/2011

Menest for Low Estrogen After Operation to Remove Ovaries

I had a hysterectomy that included my ovaries. After trying out other hormone replacement therapies, I finally found one that didn't give me any negative side effects. Menest has been great for me and I'm now on it eight years later!

5

Patient Review

2/19/2011

Menest for Low Estrogen After Operation to Remove Ovaries

I had cervical cancer when I was 32 (1986) and had everything removed. My doc put me on Menest 1.25 mg and I have been on it until June of this year. I never had problems with it. At my age now I decided to try a natural HRT.

5

Patient Review

6/22/2018

Menest for Low Estrogen After Operation to Remove Ovaries

I've been taking this for over 40 years, and it's really helped me. I don't have hot flashes anymore, and I just feel overall more well-rounded.

5

Patient Review

5/21/2008

Menest for Low Estrogen After Operation to Remove Ovaries

5

Patient Review

12/5/2008

Menest for Post-Menopausal Osteoporosis Prevention

5

Patient Review

12/14/2008

Menest for Low Estrogen After Operation to Remove Ovaries

5

Patient Review

10/22/2013

Menest for "Change of Life" Signs

This medication has helped me so much by clearing up my menopause issues. I feel like a human being again because it's improved my quality of life in such a significant way.

4.7

Patient Review

4/6/2010

Menest for Low Estrogen After Operation to Remove Ovaries

I experienced some night sweats and bruising on my breasts. I also found myself to be a bit more irritable; however, these symptoms could very well be due to the fact that I am going through menopause.

4.3

Patient Review

4/2/2009

Menest for "Change of Life" Signs

I'm using this to help with vaginal atrophy and dryness. So far, so good!

4.3

Patient Review

11/7/2008

Menest for Low Estrogen After Operation to Remove Ovaries

4

Patient Review

6/16/2014

Menest for Post-Menopausal Osteoporosis Prevention

I switched from Premarin to this medication and am finding darkening and spotting of skin on hands and arms. Otherwise I don't notice a difference. The skin discoloration is concerning, so I might switch back to Premarin.

3.7

Patient Review

3/19/2008

Menest for Vaginal Inflammation due to Loss of Hormone Stimulation

2.7

Patient Review

9/25/2009

Menest for "Change of Life" Signs

I was surprised to find that this substitute medication actually made me feel better than my previous one. I take it for mood, libido, and osteoporosis prevention, among other things. I've been taking hormones for 49 years now.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about menest

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What company makes Menest?

"The prescription medication MENEST® can be obtained by either contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com."

Answered by AI

Is Menest still on the market?

"The FDA reports that Menest (esterified estrogens; Pfizer) 2.5mg tablets have been permanently discontinued."

Answered by AI

Is Menest the same as Premarin?

"The two drugs Premarin and Menest both contain estrogen, but estrogen from two different sources. Premarin is made from the hormones of pregnant horses, while Menest is made from a combination of the hormones of pregnant horses and plant-based estrogens, including soybeans and yams."

Answered by AI

What is Menest used for?

"This medication works by supplying synthetic estrogen to the body.

This medication is a female hormone that is used by women to help reduce symptoms of menopause, such as hot flashes and vaginal dryness, caused by the body making less estrogen. This medication works by supplying synthetic estrogen to the body."

Answered by AI

Clinical Trials for Menest

Image of Erevna Innovations Inc. in Montreal, Canada.

Sculptra + Restylane for Post-Menopausal Skin Concerns

40 - 65
Female
Montreal, Canada

The post-menopausal state is marked by a sharp decline in estrogen, leading to significant structural and functional changes in the skin, including collagen loss, dryness, thinning, and reduced elasticity. To address these concerns, aesthetic injectables products such as Sculptra® Aesthetic (poly-L-lactic-acid \[PLLA- SCA\]) and Restylane Skinboosters®\[HASBV\] (small-particle hyaluronic acid - SP-HA) can be used. PLLA-SCA stimulates collagen production via cellular activation (biostimulator), gradually improving dermal structure. HASBV enhances hydration, elasticity, and skin texture when injected under the skin. Considering that hydration and laxity represent the primary aesthetic concerns in this patient population. Targeted treatment with SP-HA (HASBV) to improve hydration and PLLA-SCA to address laxity have been shown to produce significant clinical outcomes by directly addressing these key dermal deficiencies. This approach forms the basis of the current study.

Phase 4
Recruiting

Erevna Innovations Inc.

Andreas Nikolis, MD, PhD

Have you considered Menest clinical trials?

We made a collection of clinical trials featuring Menest, we think they might fit your search criteria.
Go to Trials
Image of Noll Laboratory in University Park, United States.

Estradiol and Elagolix for Menopause

42 - 64
Female
University Park, PA

The frequency and severity of heat waves has increased in the last decades. Older adults (over 65 years) have impaired responses to heat stress making them at increased risk for adverse events. Previous heat waves report that women over 65 experience worse health outcomes than any other age group and age matched men. Aging and reproductive hormones, specifically estrogen, independently alter responses to heat stress. However, the combined effects of low estrogen following menopause and aging on the response to heat stress are unknown. In this study, the investigators will identify the role of estrogen in pre and post menopausal women on thermoregulatory responses to heat stress.

Phase 4
Recruiting

Noll Laboratory

W. Larry Kenney, Ph.D.

Have you considered Menest clinical trials?

We made a collection of clinical trials featuring Menest, we think they might fit your search criteria.
Go to Trials
Image of Rehabilitation R&D Service, Baltimore, MD in Baltimore, United States.

Cognitive Behavioral Therapy for Menopause

18+
Female
Baltimore, MD

Women are the fastest-growing group of U.S. Veterans. Over half of those using VA care are 45 or older, with more age-related health concerns than civilian women. The VA urgently needs gender-informed strategies to ensure women Veterans receive tailored care that addresses their intersecting mental, physical, and age related health concerns, as well as gender-linked stressors. One prominent example is menopause, a health transition period that, for many women, can be associated with negative physical and mental health concerns that can worsen their functioning and quality of life. This project will: (1) integrate stakeholder feedback to tailor Cognitive Behavioral Therapy for Menopause (CBT-Meno) for women Veterans with menopause concerns; and (2) refine and evaluate tailored CBT-Meno as a treatment to address these intersecting needs in a clinical trial.

Waitlist Available
Has No Placebo

Rehabilitation R&D Service, Baltimore, MD (+2 Sites)

Haley Miles-McLean, PhD

Image of Student Health and Wellness Building - Department of Kinesiology in Charlottesville, United States.

Nitrate Supplementation and Exercise for Menopause

45 - 75
Female
Charlottesville, VA

Menopause greatly increases cardiovascular disease risk (CVD). Current exercise guidelines are inadequate to ameliorate this risk and higher intensity exercise may be necessary for cardiovascular benefits in postmenopausal females. Oral nitrate supplementation enhances exercise performance and CVD risk profile in several clinical conditions. The investigators recently reported that 3-days of nitrate supplementation in postmenopausal females enhances acute post-exercise vascular function, in an intensity dependent manner. The effects of nitrate supplementation and exercise training over a longer training program remains unexplored. This investigation will examine the impact of exercise training intensity with and without inorganic nitrate supplementation, on CVD and fitness outcomes. Postmenopausal females will be tested for maximal oxygen uptake and lactate threshold before randomization to one of four groups: that inorganic nitrate-rich beetroot juice, or beetroot juice with nitrate extracted; and assigned to one-month of calorie matched high-intensity or moderate-intensity exercise training. Vascular function and fitness will be evaluated before and after training.

Recruiting
Paid Trial

Student Health and Wellness Building - Department of Kinesiology

Jason Allen, PhD

Image of Neuromuscular Research Laboratory in Pittsburgh, United States.

Hormone Therapy for Musculoskeletal Health

18 - 40
All Sexes
Pittsburgh, PA

Non-combat-related muscle, tendon and bone injuries are the most common injuries suffered by military personnel, particularly in new recruits. These injuries impact military readiness and are responsible for roughly 60% of limited duty days, 65% of soldiers who are unable to deploy, and nearly $500 million in medical cost to the government annually in the Army alone. Drug interventions must be studied and developed to prevent these negative outcomes and prepare military personnel for the demands of military service. At the current time, military leadership has identified critical gaps in understanding how to minimize these injuries and train soldiers with drug intervention serving among those gaps. The goal of this study is to determine how a hormonal intervention can change muscle, tendon, and bone function as well as physical and psychological performance in response to mental and physical stress. To do so, we will examine sex hormone (testosterone, estrogen) levels, muscle, tendon, and bone images, blood samples, and physical and mental performance. We will look at things like changes in hormone levels, chemicals released from active skeletal muscles, and your body composition. The results from this study will be used to improve physical readiness training in the military with the goal of reducing injuries.

Phase 4
Recruiting

Neuromuscular Research Laboratory

Bradley C Nindl, PhD

Have you considered Menest clinical trials?

We made a collection of clinical trials featuring Menest, we think they might fit your search criteria.
Go to Trials